← Back to Search

Eye Tracking for Autism Detection (RCFET Trial)

N/A

Waitlist Available

Led By Rebecca R McNally Keehn, PhD, HSPP

Research Sponsored by Indiana University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Children must have English- or Spanish-speaking caregivers

Be younger than 18 years old

Must not have

Child is younger than 12 months or older than 48 months

Caregivers are not English- or Spanish-speaking

Timeline

Screening 3 weeks

Treatment Varies

Follow Up day 1

Awards & highlights

No Placebo-Only Group

Summary

This trial will use a special eye-tracking device called Eyelink Portable Duo to collect information about how participants' eyes move without needing to touch them.

Who is the study for?

This trial is for young children aged 12-48 months who are patients at Riley Hospital for Children in Indiana. They must have caregivers who speak English or Spanish and can give consent. It's not open to kids younger than 12 months, older than 48 months, or those with non-English/Spanish-speaking caregivers.

What is being tested?

The study is testing a non-invasive eye-tracking system called Eyelink Portable Duo to see if it can help identify the risk of autism in young children during routine health care visits.

What are the potential side effects?

Since the Eyelink Portable Duo is a non-invasive device used only to track eye movement, there are no expected side effects from its use in this study.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My child's caregiver speaks English or Spanish.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

My child is not between 1 and 4 years old.

Select...

My caregiver does not speak English or Spanish.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ day 1

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~day 1

This trial's timeline: 3 weeks for screening, Varies for treatment, and day 1 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Agreement between eye-tracking biomarker score and diagnosis

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Children Undergoing Developmental EvaluationExperimental Treatment1 Intervention

Children undergoing a standard of care developmental evaluation will be enrolled into the study. After the completion of the developmental evaluation, research participation includes a one-time eye-tracking activity in which the child will view a series of different pictures and movies while their eye movements are tracked and recorded.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Eyelink Portable Duo

2019

N/A

~160

0 / 3Eligibility criteria met